Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$35.91−0.53 (-1.45%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Nektar Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nektar Therapeutics's price to sales ratio was 14.2× on Nov 11, 2026, against 20.5× a year earlier. Over the last 5 years it ranged from 1.0× to 31.4×, with a median of 4.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.2× | +0.9 |
| 2025 | Dec 31, 2025 | 13.3× | +11.4 |
| 2024 | Dec 31, 2024 | 1.8× | +0.6 |
| 2023 | Dec 29, 2023 | 1.2× | −3.3 |
| 2022 | Dec 30, 2022 | 4.5× | −20.4 |
| 2021 | Dec 31, 2021 | 24.8× | +6.2 |
| 2020 | Dec 31, 2020 | 18.7× | −12.8 |
| 2019 | Dec 31, 2019 | 31.5× | +26.9 |
| 2018 | Dec 31, 2018 | 4.6× | −33.0 |
| 2017 | Dec 29, 2017 | 37.5× | +27.4 |
| 2016 | Dec 30, 2016 | 10.1× | −0.5 |
| 2015 | Dec 31, 2015 | 10.6× | +1.3 |
| 2014 | Dec 31, 2014 | 9.4× | −0.1 |
| 2013 | Dec 31, 2013 | 9.5× | −1.4 |
| 2012 | Dec 31, 2012 | 10.9× | +4.6 |
| 2011 | Dec 30, 2011 | 6.3× | – |
See a number that looks wrong?